Xiaoli Huang, Jia Xu, Xiaogang Hu, Juntao Yang, Menggang Liu
{"title":"Development and validation of a visual prediction model for severe acute pancreatitis: a retrospective study.","authors":"Xiaoli Huang, Jia Xu, Xiaogang Hu, Juntao Yang, Menggang Liu","doi":"10.3389/fmed.2025.1564742","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acute pancreatitis (AP) is a common acute abdominal disease. The early identification of patients at risk of progression to severe AP (SAP) is crucial for developing effective therapeutic and nursing measures. Although many scoring systems exist for SAP risk assessment, none is widely accepted. Systemic inflammatory grade (SIG) is a novel systemic inflammation-based scoring system, but its relationship with AP, as well as the SAP risk prediction model involving SIG, has not been reported.</p><p><strong>Methodology: </strong>The demographic information, clinical data, and laboratory results of patients diagnosed with AP were collected. Baseline comparisons were made using the Wilcoxon rank-sum test, chi-square test and Fisher's exact test. Logistic regression analyses were used to identify independent predictors of SAP; these factors were then used to establish a nomogram model. The model's predictive efficacy and threshold values were evaluated using the receiver operating characteristic (ROC) curve and calibration curve. The decision curve analysis (DCA) and clinical impact curve (CIC) were used to further evaluate the benefit of the model.</p><p><strong>Results: </strong>Five hundred and ninety-two patients aged 18-92 years (median, 43 years) were included. In two stepwise regressions, SIG, C-reactive protein (CRP), prognostic nutritional index (PNI), and white blood cell (WBC) were all considered independent risk factors for SAP (<i>p</i> < 0.05). A nomogram prediction model was constructed using these four factors, with an area under the curve (AUC) of 0.940 (95% CI: 0.907-0.972, <i>p</i> < 0.01). The AUC-ROC for 10-fold cross-validation was 0.942 ± 0.065. The results of the Hosmer and Lemeshow goodness of fit (GoF) test (<i>p</i>-value = 0.596) and the Brier score (0.031, 95% CI 0.020-0.042), as well as the calibration curve, all demonstrated that the model exhibits good accuracy. DCA and CIC curves showed that the model provided good predictive value.</p><p><strong>Conclusion: </strong>SIG, CRP, PNI, and WBC represent promising early prognostic markers for severe acute pancreatitis (SAP). A nomogram prediction model utilizing these markers offers effective early prediction for SAP.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1564742"},"PeriodicalIF":3.1000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12263550/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1564742","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Acute pancreatitis (AP) is a common acute abdominal disease. The early identification of patients at risk of progression to severe AP (SAP) is crucial for developing effective therapeutic and nursing measures. Although many scoring systems exist for SAP risk assessment, none is widely accepted. Systemic inflammatory grade (SIG) is a novel systemic inflammation-based scoring system, but its relationship with AP, as well as the SAP risk prediction model involving SIG, has not been reported.
Methodology: The demographic information, clinical data, and laboratory results of patients diagnosed with AP were collected. Baseline comparisons were made using the Wilcoxon rank-sum test, chi-square test and Fisher's exact test. Logistic regression analyses were used to identify independent predictors of SAP; these factors were then used to establish a nomogram model. The model's predictive efficacy and threshold values were evaluated using the receiver operating characteristic (ROC) curve and calibration curve. The decision curve analysis (DCA) and clinical impact curve (CIC) were used to further evaluate the benefit of the model.
Results: Five hundred and ninety-two patients aged 18-92 years (median, 43 years) were included. In two stepwise regressions, SIG, C-reactive protein (CRP), prognostic nutritional index (PNI), and white blood cell (WBC) were all considered independent risk factors for SAP (p < 0.05). A nomogram prediction model was constructed using these four factors, with an area under the curve (AUC) of 0.940 (95% CI: 0.907-0.972, p < 0.01). The AUC-ROC for 10-fold cross-validation was 0.942 ± 0.065. The results of the Hosmer and Lemeshow goodness of fit (GoF) test (p-value = 0.596) and the Brier score (0.031, 95% CI 0.020-0.042), as well as the calibration curve, all demonstrated that the model exhibits good accuracy. DCA and CIC curves showed that the model provided good predictive value.
Conclusion: SIG, CRP, PNI, and WBC represent promising early prognostic markers for severe acute pancreatitis (SAP). A nomogram prediction model utilizing these markers offers effective early prediction for SAP.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world